Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
onsemi stock logo
ON
onsemi
$117.00
-3.2%
$97.39
$44.56
$134.92
$47.38B1.9711.36 million shs16.83 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.67
+0.2%
$26.56
$23.11
$28.75
$146.02B0.3431.30 million shs35.04 million shs
RH stock logo
RH
RH
$150.48
+2.5%
$133.67
$106.30
$257.00
$2.77B1.91814,339 shs1.08 million shs
Roche Holding AG stock logo
RHHBY
Roche
$50.23
-0.6%
$50.97
$37.51
$60.85
$322.03B0.52.54 million shs1.24 million shs
Roche Holding AG stock logo
RHHVF
Roche
$399.00
+0.5%
$404.96
$300.15
$490.33
N/AN/A17,804 shs307 shs
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$15.89
+2.2%
$19.61
$10.41
$40.90
$1.64B0.212.86 million shs2.44 million shs
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$5.78
+1.4%
$6.83
$5.02
$21.73
$1.10B-1.333.93 million shs3.80 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
onsemi stock logo
ON
onsemi
+3.10%-0.02%+17.17%+102.89%+140.98%
Pfizer Inc. stock logo
PFE
Pfizer
-1.49%+0.14%+0.03%-5.41%+9.82%
RH stock logo
RH
RH
+0.29%-1.50%+9.90%+2.75%-19.73%
Roche Holding AG stock logo
RHHBY
Roche
-1.81%+0.66%-1.06%-5.41%+23.72%
Roche Holding AG stock logo
RHHVF
Roche
-4.23%+2.76%-2.97%-9.44%+21.01%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-1.27%-11.70%-22.06%-11.95%-63.85%
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
-0.52%-8.95%-20.61%-58.55%-21.05%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
onsemi stock logo
ON
onsemi
$117.00
-3.2%
$97.39
$44.56
$134.92
$47.38B1.9711.36 million shs16.83 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.67
+0.2%
$26.56
$23.11
$28.75
$146.02B0.3431.30 million shs35.04 million shs
RH stock logo
RH
RH
$150.48
+2.5%
$133.67
$106.30
$257.00
$2.77B1.91814,339 shs1.08 million shs
Roche Holding AG stock logo
RHHBY
Roche
$50.23
-0.6%
$50.97
$37.51
$60.85
$322.03B0.52.54 million shs1.24 million shs
Roche Holding AG stock logo
RHHVF
Roche
$399.00
+0.5%
$404.96
$300.15
$490.33
N/AN/A17,804 shs307 shs
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$15.89
+2.2%
$19.61
$10.41
$40.90
$1.64B0.212.86 million shs2.44 million shs
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$5.78
+1.4%
$6.83
$5.02
$21.73
$1.10B-1.333.93 million shs3.80 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
onsemi stock logo
ON
onsemi
+3.10%-0.02%+17.17%+102.89%+140.98%
Pfizer Inc. stock logo
PFE
Pfizer
-1.49%+0.14%+0.03%-5.41%+9.82%
RH stock logo
RH
RH
+0.29%-1.50%+9.90%+2.75%-19.73%
Roche Holding AG stock logo
RHHBY
Roche
-1.81%+0.66%-1.06%-5.41%+23.72%
Roche Holding AG stock logo
RHHVF
Roche
-4.23%+2.76%-2.97%-9.44%+21.01%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-1.27%-11.70%-22.06%-11.95%-63.85%
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
-0.52%-8.95%-20.61%-58.55%-21.05%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
onsemi stock logo
ON
onsemi
2.50
Moderate Buy$92.96-20.55% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.25
Hold$28.8212.30% Upside
RH stock logo
RH
RH
2.10
Hold$174.8016.16% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.45
Hold$51.502.53% Upside
Roche Holding AG stock logo
RHHVF
Roche
0.00
N/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2.07
Hold$24.7755.90% Upside
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
2.87
Moderate Buy$27.25371.45% Upside

Current Analyst Ratings Breakdown

Latest SRPT, PFE, WVE, RHHBY, ON, RH, and RHHVF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeUnderperformSector Perform
6/9/2026
onsemi stock logo
ON
onsemi
Boost Price TargetOverweight$115.00 ➝ $140.00
6/9/2026
RH stock logo
RH
RH
Lower Price TargetNeutral$160.00 ➝ $155.00
6/1/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral
5/28/2026
onsemi stock logo
ON
onsemi
Boost Price TargetOutperform$130.00 ➝ $150.00
5/27/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
5/26/2026
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
DowngradeSell (D+)Sell (D)
5/26/2026
onsemi stock logo
ON
onsemi
Boost Price TargetBuy$115.00 ➝ $138.00
5/20/2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
Boost Price TargetOverweight$13.00 ➝ $14.00
5/19/2026
onsemi stock logo
ON
onsemi
Boost Price TargetOutperform$120.00 ➝ $130.00
5/19/2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
Lower Price TargetBuy$18.00 ➝ $13.00
(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
onsemi stock logo
ON
onsemi
$6.00B7.65$4.00 per share29.24$19.12 per share6.12
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.34$4.40 per share5.83$15.26 per share1.68
RH stock logo
RH
RH
$3.44B0.83$20.64 per share7.29$3.23 per share46.59
Roche Holding AG stock logo
RHHBY
Roche
$76.45B4.19$3.58 per share14.04$7.18 per share7.00
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$2.20B0.76N/AN/A$10.89 per share1.46
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$42.73M26.03N/AN/A$3.10 per share1.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
onsemi stock logo
ON
onsemi
$121M$1.4182.9826.831.089.46%12.79%7.80%8/3/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.598.97N/A11.83%19.44%8.41%8/4/2026 (Estimated)
RH stock logo
RH
RH
$124.79M$6.3123.8515.472.453.63%-567.82%2.62%6/11/2026 (Estimated)
Roche Holding AG stock logo
RHHBY
Roche
$15.55BN/AN/A14.314.16N/AN/AN/A7/23/2026 (Estimated)
Roche Holding AG stock logo
RHHVF
Roche
N/A$10.8136.91N/AN/AN/AN/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
-$713.41M-$0.96N/A6.110.16-2.94%7.56%2.94%8/5/2026 (Estimated)
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
-$204.38M-$1.06N/AN/AN/A-255.70%-56.76%-42.80%7/30/2026 (Estimated)

Latest SRPT, PFE, WVE, RHHBY, ON, RH, and RHHVF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/11/2026Q1 2027
RH stock logo
RH
RH
-$2.0903N/AN/AN/A$792.55 millionN/A
5/6/2026Q1 2026
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$0.9760$3.16+$2.1840$2.88$474.16 million$730.80 million
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
5/4/2026Q1 2026
onsemi stock logo
ON
onsemi
$0.6130$0.64+$0.0270-$0.08$1.49 billion$1.51 billion
4/29/2026Q1 2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
-$0.34-$0.13+$0.21-$0.13$8.45 million$38.25 million
3/31/2026Q4 2026
RH stock logo
RH
RH
$2.21$1.53-$0.68$1.46$873.48 million$842.62 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
onsemi stock logo
ON
onsemi
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.70%-13.20%131.30%16 Years
RH stock logo
RH
RH
N/AN/AN/AN/AN/A
Roche Holding AG stock logo
RHHBY
Roche
$0.971.93%N/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
$7.801.95%N/A72.16%N/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
N/AN/AN/AN/AN/A
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
N/AN/AN/AN/AN/A

Latest SRPT, PFE, WVE, RHHBY, ON, RH, and RHHVF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
onsemi stock logo
ON
onsemi
0.41
4.87
3.14
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94
RH stock logo
RH
RH
51.28
1.19
0.31
Roche Holding AG stock logo
RHHBY
Roche
0.72
1.38
1.12
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
0.56
4.63
2.62
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
N/A
11.26
11.26

Institutional Ownership

CompanyInstitutional Ownership
onsemi stock logo
ON
onsemi
97.70%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
RH stock logo
RH
RH
90.17%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
29.01%
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
86.68%
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
89.73%

Insider Ownership

CompanyInsider Ownership
onsemi stock logo
ON
onsemi
0.35%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
RH stock logo
RH
RH
26.90%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
N/A
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
6.90%
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
24.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
onsemi stock logo
ON
onsemi
22,670391.90 million390.53 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
RH stock logo
RH
RH
7,23018.90 million13.82 millionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,2496.37 billionN/ANot Optionable
Roche Holding AG stock logo
RHHVF
Roche
103,605N/AN/ANot Optionable
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1,372105.58 million98.29 millionOptionable
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
240192.40 million145.65 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
onsemi stock logo

onsemi NASDAQ:ON

$117.00 -3.90 (-3.23%)
Closing price 04:00 PM Eastern
Extended Trading
$116.32 -0.68 (-0.58%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

onsemi is engaged in disruptive innovations and also a supplier of power and analog semiconductors. The firm offers vehicle electrification and safety, sustainable energy grids, industrial automation, and 5G and cloud infrastructure, with a focus on automotive and industrial end-markets. It operates through the following segments: Power Solutions Group, Advanced Solutions Group, and Intelligent Sensing Group. The Power Solutions Group segment offers discrete, module, and semiconductor products that perform multiple application functions, including power switching, power conversion, signal conditioning, circuit protection, signal amplification, and voltage reference functions. The Advanced Solutions Group segment is involved in the designing and developing of analog, mixed-signal, advanced logic, ASSPs and ASICs, Wi-Fi and power solutions for a broad base of end-users in the automotive, consumer, computing, industrial, communications, medical and aerospace/defense markets. The Intelligent Sensing Group segment is focused on the designing and developing of CMOS and CCD image sensors, as well as proximity sensors, image signal processors, single photon detectors, inclu

Pfizer stock logo

Pfizer NYSE:PFE

$25.67 +0.05 (+0.18%)
Closing price 03:59 PM Eastern
Extended Trading
$25.70 +0.04 (+0.15%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

RH stock logo

RH NYSE:RH

$150.48 +3.68 (+2.51%)
Closing price 03:59 PM Eastern
Extended Trading
$149.40 -1.08 (-0.72%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.

Roche stock logo

Roche OTCMKTS:RHHBY

$50.23 -0.32 (-0.63%)
As of 03:59 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche stock logo

Roche OTCMKTS:RHHVF

$399.00 +2.16 (+0.55%)
As of 03:53 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Sarepta Therapeutics stock logo

Sarepta Therapeutics NASDAQ:SRPT

$15.89 +0.34 (+2.19%)
Closing price 04:00 PM Eastern
Extended Trading
$15.65 -0.24 (-1.51%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

WAVE Life Sciences stock logo

WAVE Life Sciences NASDAQ:WVE

$5.78 +0.08 (+1.40%)
Closing price 04:00 PM Eastern
Extended Trading
$5.74 -0.04 (-0.61%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.